Evidence map›Paper›PMID 34796279›Full record

ArticleWellcome open research2021

Rapid design and implementation of an adaptive pooling workflow for SARS-CoV-2 testing in an NHS diagnostic laboratory: a proof-of-concept study.

Michael Crone, Paul Randell, Zoey Herm, Arthi Anand, Saghar Missaghian-Cully, Loren Perelman, Panagiotis Pantelidis, Paul Freemont

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Biofoundries are a nucleating hub for industrial translation.Synthetic biology (Oxford, England) · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael CroneLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 84 Wood Lane, London, W12 0BZ, UK.ORCID https://orcid.org/0000-0002-5675-0172
Paul RandellDepartment of Infection and Immunity, North West London Pathology, London, UK.
Zoey HermRiffyn, Inc., 484 9th Street, Oakland, California, 94607, USA.
Arthi AnandHistocompatibility and Immunogenetics Laboratories, Department of Infection and Immunity, North West London Pathology, London, UK.
Saghar Missaghian-CullyImperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.
Loren PerelmanRiffyn, Inc., 484 9th Street, Oakland, California, 94607, USA.
Panagiotis PantelidisDepartment of Infection and Immunity, North West London Pathology, London, UK.
Paul FreemontLondon Biofoundry, Imperial College Translation and Innovation Hub, White City Campus, 84 Wood Lane, London, W12 0BZ, UK.
Imperial College Healthcare NHS Trust · GBUniversity of Surrey · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnosticslaboratory automationSARS-CoV-2

Identifiers

PMID34796279
PMCPMC8591522
OpenAlexW3207095552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.